NDC Code(s) : 61786-868-19
Packager : REMEDYREPACK INC.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
ATORVASTATIN CALCIUMATORVASTATIN CALCIUM TABLET, FILM COATED | ||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
PRINCIPAL DISPLAY PANEL
DRUG: ATORVASTATIN CALCIUM
GENERIC: ATORVASTATIN CALCIUM
DOSAGE: TABLET, FILM COATED
ADMINSTRATION: ORAL
NDC: 61786-868-19
COLOR: white
SHAPE: OVAL
SCORE: No score
SIZE: 9 mm
IMPRINT: APO;A10
PACKAGING: 90 in 1 BOTTLE
ACTIVE INGREDIENT(S):
- ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE 10mg in 1
INACTIVE INGREDIENT(S):
- CALCIUM ACETATE
- HYPROMELLOSES
- HYDROXYPROPYL CELLULOSE (TYPE H)
- POLYETHYLENE GLYCOL 8000
- SILICON DIOXIDE
- CROSCARMELLOSE SODIUM
- MAGNESIUM STEARATE
- SODIUM CARBONATE
- CELLULOSE, MICROCRYSTALLINE
- TITANIUM DIOXIDE